216 related articles for article (PubMed ID: 9404528)
1. [Tolperisone in spasticity and muscle spasm. Tolperisone in multiple sclerosis].
Nervenarzt; 1996 Jul; 67(7 Suppl Tolperison):1-4. PubMed ID: 9404528
[No Abstract] [Full Text] [Related]
2. [Spastic syndrome. More mobile again after stroke].
MMW Fortschr Med; 2001 Mar; 143(10):46. PubMed ID: 11268740
[No Abstract] [Full Text] [Related]
3. [Effectiveness and safety of tolperisone in spasticity following cerebral stroke: randomized, double-blind, placebo-controlled trial].
Lipták J
Ideggyogy Sz; 2013 Jul; 66(7-8):283-4. PubMed ID: 23971362
[No Abstract] [Full Text] [Related]
4. [To make easier everyday life of stroke patients. Muscle relaxants diminish spasms].
MMW Fortschr Med; 2003 Feb; 145(9):57. PubMed ID: 12666538
[No Abstract] [Full Text] [Related]
5. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
Agarwal S; Patel T; Shah N; Patel BM
Biomed Pharmacother; 2017 Mar; 87():628-635. PubMed ID: 28086137
[TBL] [Abstract][Full Text] [Related]
6. [The use of midokalm in patients with multiple sclerosis].
Lashch NIu; Avakian GN
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(6):24-8. PubMed ID: 10900684
[No Abstract] [Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke.
Stamenova P; Koytchev R; Kuhn K; Hansen C; Horvath F; Ramm S; Pongratz D
Eur J Neurol; 2005 Jun; 12(6):453-61. PubMed ID: 15885050
[TBL] [Abstract][Full Text] [Related]
8. [A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke].
Stamenova P; Koytchev R; Kuhn K; Hanasen C; Horvath F; Ramm S; Pongratz D
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):34-42. PubMed ID: 16457132
[TBL] [Abstract][Full Text] [Related]
9. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
[No Abstract] [Full Text] [Related]
10. [Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].
Kocsis P; Tarnawa I; Kovács G; Szombathelyi Z; Farkas S
Acta Pharm Hung; 2002; 72(1):49-61. PubMed ID: 12426787
[TBL] [Abstract][Full Text] [Related]
11. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
Lipták J
Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
[No Abstract] [Full Text] [Related]
12. [The administration of midocalm in the treatment of vertebrogenic algesic syndromes].
Avakian GN; Chukanova EI; Nikonov AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(5):26-31. PubMed ID: 10849963
[No Abstract] [Full Text] [Related]
13. A phase IV observational multi-centre, open-label study on efficacy and safety of tolperisone 150 mg in patients with painful muscle spasm associated with degenerative or inflammatory diseases of the musculoskeletal system.
Prabhoo R; Keny S; Prabhoo T; Singh A; Rana R
J Assoc Physicians India; 2011 Jan; 59():33-7. PubMed ID: 21751662
[TBL] [Abstract][Full Text] [Related]
14. [Talperison in spasticity and and muscle rigidity].
Orthopade; 1996 Aug; 25(4 Suppl):1-4. PubMed ID: 9022397
[No Abstract] [Full Text] [Related]
15. [Patient with chronic backache. Disabled or muscle spasm patient?].
MMW Fortschr Med; 2002 Dec; 144(49):61. PubMed ID: 12577750
[No Abstract] [Full Text] [Related]
16. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial.
Pratzel HG; Alken RG; Ramm S
Pain; 1996 Oct; 67(2-3):417-25. PubMed ID: 8951937
[TBL] [Abstract][Full Text] [Related]
17. [New therapies for spastic movement disorders].
Benecke R; Patejdl R
MMW Fortschr Med; 2009 Oct; 151 Suppl 3():118-22. PubMed ID: 20623938
[No Abstract] [Full Text] [Related]
18. [Restorative treatment of degenerative-dystrophic diseases of large joints].
Neverov VA; Kurbanov SKh
Vestn Khir Im I I Grek; 2004; 163(2):97-8. PubMed ID: 15199782
[TBL] [Abstract][Full Text] [Related]
19. Novel Treatment Using Intravenous Dantrolene Sodium for Postoperative Exacerbated Spasticity in Multiple Sclerosis: A Case Report.
Sturgill EL; Wittwer RL
A A Pract; 2018 Jul; 11(1):25-27. PubMed ID: 29851691
[TBL] [Abstract][Full Text] [Related]
20. The effect of Dantrium on spasticity in multiple sclerosis.
Ladd H; Oist C; Jonsson B
Acta Neurol Scand; 1974; 50(4):397-408. PubMed ID: 4277694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
